loadpatents
name:-0.34997391700745
name:-0.024758815765381
name:-0.0047399997711182
Figg; William D. Patent Filings

Figg; William D.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Figg; William D..The latest application filed is for "hypoxia-inducible factor 1 (hif-1) inhibitors".

Company Profile
1.15.13
  • Figg; William D. - Fairfax VA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Hypoxia-inducible factor 1 (HIF-1) inhibitors
Grant 10,246,463 - Gustafson , et al.
2019-04-02
SLCO1B3 genotype
Grant 10,094,836 - Figg , et al. October 9, 2
2018-10-09
Hypoxia-inducible Factor 1 (hif-1) Inhibitors
App 20180093995 - Gustafson; Kirk R. ;   et al.
2018-04-05
Aza-epoxy-guaiane derivatives and treatment of cancer
Grant 9,676,788 - Chain , et al. June 13, 2
2017-06-13
Aza-epoxy-guaiane Derivatives And Treatment Of Cancer
App 20160347764 - Chain; William J. ;   et al.
2016-12-01
Thalidomide Analogs
App 20140309436 - Greig; Nigel H. ;   et al.
2014-10-16
Thalidomide analogs
Grant 8,853,253 - Greig , et al. October 7, 2
2014-10-07
ABCB1 genotyping to predict microtubule-stabilizing-agent-induced toxicity
Grant 8,835,115 - Figg , et al. September 16, 2
2014-09-16
Analogs of thalidomide as potential angiogenesis inhibitors
Grant 8,716,315 - Figg , et al. May 6, 2
2014-05-06
Thalidomide analogs
Grant 8,546,430 - Greig , et al. October 1, 2
2013-10-01
Thalidomide Analogs
App 20130035363 - Greig; Nigel H. ;   et al.
2013-02-07
Tetrahalogenated compounds useful as inhibitors of angiogenesis
Grant 8,143,252 - Figg , et al. March 27, 2
2012-03-27
Thalidomide Analogs
App 20110245210 - Greig; Nigel H. ;   et al.
2011-10-06
Thalidomide analogs
Grant 7,973,057 - Greig , et al. July 5, 2
2011-07-05
Slco1b3 Genotype
App 20100317726 - Figg; William D. ;   et al.
2010-12-16
Cyp1B1 Genotype
App 20100280084 - Figg; William D. ;   et al.
2010-11-04
Abcb1 Genotyping To Predict Microtubule-stabilizing-agent-induced Toxicity
App 20100247481 - Figg; William D. ;   et al.
2010-09-30
Materials And Methods For Abcb1 Polymorphic Variant Screening, Diagnosis, And Treatment
App 20090325156 - Figg; William D. ;   et al.
2009-12-31
Tetrahalogenated compounds useful as inhibitors of angiogenesis
App 20090186913 - Figg; William D. ;   et al.
2009-07-23
Analogs of thalidomide as potential angiogenesis inhibitors
Grant 7,320,991 - Figg , et al. January 22, 2
2008-01-22
Analogs of thalidomide as potential angiogenesis inhibitors
App 20070293519 - Figg; William D. ;   et al.
2007-12-20
Analogs of thalidomide as potential angiogenesis inhibitors
App 20040077685 - Figg, William D. ;   et al.
2004-04-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed